Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Link to SEPIO compliant JSON-LD document
  • There was no gene found in the curated document received from the VCI/VCEP
  • Gene listed was thus derived from ClinVar and/or CAR

Variant: NM_001482.3(GATM):c.407C>T (p.Thr136Met)

CA314868

205613 (ClinVar)

Gene: GATM
Condition: AGAT deficiency
Inheritance Mode: Autosomal recessive inheritance
Link to MONDO
UUID: 8ecdc806-d5b5-4a80-98a9-ce7424f5b9aa
Approved on: 2023-01-25
Published on: 2023-01-25

HGVS expressions

NM_001482.3(GATM):c.407C>T (p.Thr136Met)
NC_000015.10:g.45369403G>A
CM000677.2:g.45369403G>A
NC_000015.9:g.45661601G>A
CM000677.1:g.45661601G>A
NC_000015.8:g.43448893G>A
NG_011674.1:g.14380C>T
NG_011674.2:g.37915C>T
ENST00000396659.8:c.407C>T
ENST00000674905.1:c.407C>T
ENST00000675158.1:c.407C>T
ENST00000675323.1:c.407C>T
ENST00000675701.1:c.347C>T
ENST00000675974.1:n.498C>T
ENST00000676090.1:c.*1138C>T
ENST00000396659.7:c.407C>T
ENST00000558118.1:c.*212C>T
ENST00000558163.1:c.188C>T
ENST00000558336.5:c.407C>T
ENST00000558362.5:n.2063C>T
ENST00000558537.5:c.20C>T
ENST00000558916.1:n.305C>T
ENST00000559885.1:c.20C>T
ENST00000561148.5:c.20C>T
NM_001482.2:c.407C>T
NM_001321015.1:c.20C>T
NM_001482.3:c.407C>T
NM_001321015.2:c.20C>T

Benign

Met criteria codes 3
BA1 BS3_Supporting BP4
Not Met criteria codes 3
PP3 PM2 PS3

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GATM Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_001482.3:c.407C>T variant in GATM is a missense variant predicted to cause substitution of threonine by methionine at amino acid 136 (p.Thr136Met). The highest population minor allele frequency in gnomAD v2.1.1 is 0.0007357 (95/129130 alleles) in the non-Finnish European population, which is higher than the ClinGen CCDS VCEP’s threshold for BA1 (>0.0005), and therefore meets this criterion (BA1). Expression of the variant in HeLa cells resulted in >50% wild type AGAT activity suggesting that this variant does not significantly impact protein function (PMID: 27233232) (BS3_Supporting). The computational predictor REVEL gives a score of 0.049 which is below the threshold of 0.15, evidence that does not predict a damaging effect on AGAT function (BP4). There is a ClinVar entry for this variant (Variation ID: 205613). In summary, this variant meets the criteria to be classified as benign for AGAT deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel (Specifications Version 1.0): BA1, BS3_Supporting, BP4. (Classification approved by the ClinGen CCDS VCEP on January 25, 2023).
Met criteria codes
BA1
0.074% in non-Finnish European population in gnomAD
BS3_Supporting
>30% normal AGAT activity when expressed in HeLa cells.
When expressed in HeLa cells, the p.Thr136Met variant exhibited >50% of wildtype enzymatic activity. PubMed:27233232
BP4
REVEL = 0.049
Not Met criteria codes
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
0.074% in non-Finnish European population in gnomAD
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.